Listen: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas

How should pharma treat Russia? Why can't Congress pass a drug pricing bill? And what does wastewater portend for the pandemic? All that and more on the latest episode of…

How should pharma treat Russia? Why can’t Congress pass a drug pricing bill? And what does wastewater portend for the pandemic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss the drug industry’s response to Russia’s invasion of Ukraine, and STAT reporter Isabella Cueto joins us to explain how the war has affected the quietly vibrant Ukrainian biotech industry. Then, STAT Washington correspondent Nicholas Florko calls in to review Congress’ years of failure to pass laws on drug pricing and examine whether bipartisan support can ever result in actual legislation. We also run through the latest news in the life sciences, including Ashish Jha’s new job, global Covid-19 surges, and a long-delayed manuscript from Biogen.

Read the rest…